For the past 28 years, PharmaVentures has acted as advisor on over 900 deal related projects covering licensing, mergers, acquisitions, divestments, and joint venture activities for companies world-wide
We have unrivalled strategic insight in the commercialisation and transaction of assets and companies in the pharmaceutical, biotech, medtech and diagnostics sectors. We have been trusted by major corporations, high growth biotechs and emerging companies to provide insight and advice to help these businesses achieve their strategic goals. Operating globally in M&A, licensing, divestments and fundraising, we have the skills and experience to help you drive your business forwards.
PharmaVentures attends key conferences and meetings to discuss our services and we also attend events on behalf of our clients, promoting advisory mandates in M&A and licensing across the life science sector.
How To Meet Us
We often have opportunities that could be transformative to your business, especially with the optimal strategy and best execution.
Our team attending these events are available to speak with you about your own requirements. To book a meeting, email us at:
10-11 MARCH 2021
Sachs Associates 14th Annual European Lifesciences CEO Forum
For partnering and investment
24 SEPTEMBER 2020
SeoulBioHub Virtual Conference
Adrian Dawkes, Managing Director and Summer Park, Senior Business Development Director delivered a number of sessions on Day 1 of the conference.
- BD101: Business Development for Beginners (Korean),
- Negotiating a Deal for a Successful Partnership (English)
- Changing Deal Trends: How do Korean Biopharmaceutical companies fit into the Deal landscape? (English/Korean mix)
- YouTube Live Q&A (Korean).
9-11 SEPTEMBER 2020
KoNECT-MO, HW-MFDS International Conference
Summer Park, Senior Business Development Director
Development delivered a session on Doing a Deal with the Post-Deal Alliance in Mind during the event.
1-3 SEPTEMBER 2020
Biotechgate Digital Partnering
Summer Park, Senior Business Development Director attended this virtual event.
The impact of conference cancellations on dealmaking
during the Covid-19 pandemic
Can Partnering Conference Cancellations Affect Dealmaking in 2020?
We all got used to the partnering conference circuit as a means to introduce the latest developments to potential partners. So now they are all temporarily suspended whilst we overcome the current global health challenge, how do you make sure your opportunities are still getting in front of your potential partners.
PharmaVentures has been successfully connecting buyers and sellers for over 28 years with and without partnering conferences.
PharmaVentures’ CEO, Dr. Fintan Walton talks about how PharmaVentures is continuing a business as usual approach for all of our clients.
Don’t hesitate to contact us to help you carry on dealmaking.